Piracetam 800 mg 120 capsules

 -Description-

Piracetam (also called 2-oxo-Pyrrolidine Acetamide, Nootropil) is a derivative of the neurotransmitter GABA (Gamma Amino Butyric Acid). Chemically related to the amino acid Pyroglutamic Acid (Pyrrolidine Carboxylic acid), which occurs in cerebrospinal fluid and plays an important role in cognitive functioning.

Piracetam 800 mg 120 capsules.

-Neurochemical Effects-

-Enhances Brain Metabolism (By increasing Glucose Utilization, Blood & Oxygen Flow) [Boosts mental energy & cerebral circulation].

-Increases Cerebral Phospholipids & Cellular Membrane Fluidity (By interacting with the polar head moieties of the phospholipid bilayer) [Supports healthy neuron communication & structure].

-Supports Cognitive Receptors (By amplifying the density of the Muscarinic Cholinergic [Frontal Cortex, Striatum, & Hippocampus], NMDA (N-Methyl-D-Aspartate) [Hippocampus], & AMPA (Alpha-amino-3-hydroxy-5-Methyl-4-isoxazole-Propionic Acid) [Cerebral Cortex] Receptors) [Strengthens neurotransmitter receptors involved in memory and neuroprotection].

-Stimulates the Corpus Callosum, an area of the brain that controls communication between the left and right hemispheres (Increases communication between both hemispheres) [Involved in speech and creative thinking].

- Stimulates the Locus Coeruleus, (specialized neurons) [Involved in information processing, attention, cortical/behavioral arousal, learning and memory]

-Inhibits Platelet Aggregation (By increasing Red-White blood cells & Platelet deformability, inhibiting thromboxane A2 synthetase or antagonism of thromboxane A2, reducing von Willebrand's factor & fibrinogen levels) [Supports Healthy Blood Flow].

-Decreases EEG complexity (Increases cooperatively of brain functional processing) [Positively effects Neuro-Electrical Functioning].

-Has a significant antioxidant effect.

-Overview-

Piracetam positively supports healthy cognitive & cardiovascular functioning by a multifaceted means of action.

-Notes-

Approved & used since 1970’s worldwide (Europe, Asia, and South American) for various health conditions. Recommended by many healthcare professionals and health organizations, such as the Life Extension Foundation.

-Dose-

6-12 capsules daily.

-When can I feel it?-

Works within an hour to a few days.

-What works best with it?-

Centrophenoxine, L-Huperzine A, Pyritinol, and Aniracetam.

-Research-

Int J Psychophysiol 1999 Oct;34(1):81-7 Single-dose piracetam effects on global complexity measures of human spontaneous multichannel EEG.

Kondakor I, Michel CM, Wackermann J, Koenig T, Tanaka H, Peuvot J, Lehmann D. The KEY Institute for Brain-Mind Research, University Hospital of Psychiatry, Zurich, Switzerland. nootropils

The results indicate that a single dose of piracetam dose-dependently affects the spontaneous EEG in normal volunteers, showing effects at the lowest treatment level. The decreased EEG complexity is interpreted as increased cooperativity of brain functional processes.

Electroencephalogr Clin Neurophysiol 1993 Mar;86(3):193-8 Global dimensional complexity of multi-channel EEG indicates change of human brain functional state after a single dose of a nootropic drug.

Wackermann J, Lehmann D, Dvorak I, Michel CM. Department of Neurology, University Hospital, Zurich, Switzerland.

In 5 normal volunteers, 4 records of 16-channel resting EEG were obtained during each of 4 randomized sessions (double blind design) after a single dose of placebo or 2.9 g or 4.8 g or 9.6 g piracetam.



Thus, the subtle change of brain global functional state after a single dose of piracetam is reflected by the non-linear measure of global dimensional complexity of the multi-channel EEG.

Neuropsychobiology 1993;28(4):212-21 Single doses of piracetam affect 42-channel event-related potential microstate maps in a cognitive paradigm.

Michel CM, Lehmann D. Department of Neurology, University Hospital, Zurich, Switzerland.

We examined whether a single administration of piracetam produces dose-dependent effects on brain functions in healthy young men. In 6 subjects, 42-channel event-related EEG potential maps (ERP) were recorded during a task requiring subjects to watch single digits presented in a pseudorandom order on a screen and to press a button after all triplets of three consecutive odd or even digits.



These segments were tested for direct effects on brain function of three single doses of piracetam (2.9, 4.8 or 9.6 g) and a placebo given double-blind in balanced order. Piracetam mainly affected the map landscape of the time segments following the triplet's last digit. U-shaped dose-dependent effects were found; they were strongest after 4.8 g piracetam. Since these particular ERP segments are recognized to be strongly correlated to cognitive functions, the present findings suggest that single medium doses of piracetam selectively activate differently located or oriented neurons during cognitive steps of information processing.

Psychopharmacology (Berl) 1976 Sep 29;49(3):307-9 Increase in the power of human memory in normal man through the use of drugs.

Dimond SJ, Brouwers EM.

Nootropyl (Piracetam) a drug reported to facilitate learning in animals was tested for its effect on man by administering it to normal volunteers. The subjects were given 3x4 capsules at 400 mg per day, in a double blind study. Each subject learned series of words presented as stimuli upon a memory drum. No effects were observed after 7 days but after 14 days verbal learning had significantly increased.

Acta Psychiatr Scand 1976 Aug;54(2):150-60 Piracetam-induced improvement of mental performance. A controlled study on normally aging individuals.

Mindus P, Cronholm B, Levander SE, Schalling D.

A double-blind, intra-individual cross-over comparison of the mental performance of 18 aging, non-deteriorated individuals during two 4-week periods of piracetam (1-acetamide-2-pyrrolidone) and placebo administration was performed using conventional and computerized perceptual-motor tasks. In a majority of these tasks the subjects did significantly better when on piracetam than on placebo, a finding consistent with ratings completed by two independent observers.

These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.